Georgia Tomaras
Professor (with tenure), Department of Surgery
Professor, Department of Immunology
Professor, Department of Molecular Genetics and Microbiology
Dr. Tomaras' overall research program is to understand the cellular and humoral immune response to HIV-1 infection and vaccination that are involved in protection from HIV-1. The research in the Tomaras laboratory centers around three main projects involving 1) antiviral CD8 T cell responses in HIV-1 infection and post vaccination, 2) mucosal and systemic antibody responses to infection and vaccination in both non-human primates and humans and 3) the ontogeny of neutralizing antibodies in HIV-1 infection. Her laboratory is also within the Duke Human Vaccine Institute.
Projects
-
Improved Global HIV-1 Incidence Assay
United States
Publications
-
Mattathil JG, Volz A, Onabajo OO, Maynard S, Bixler SL, Shen XX, et al. Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251. Nat Commun. 2023 Mar 7;14(1):1264.Cohen KW, Fiore-Gartland A, Walsh SR, Yusim K, Frahm N, Elizaga ML, et al. Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults. J Clin Invest. 2023 Feb 15;133(4).Li K, Horn GQ, Abraha M, Spreng RL, Alam SM, Hill AVS, et al. Higher antigen occupancy of high avidity CSP serum antibodies associates with protection against human malaria. Biophysical Journal. 2023 Feb 10;122(3S1):144a-145a.Callaway HM, Hastie KM, Schendel SL, Li H, Yu X, Shek J, et al. Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium. Cell Rep. 2023 Jan 31;42(1):112014.
See more publications at Scholars@Duke